| Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials G Grosso, A Pajak, S Marventano, S Castellano, F Galvano, C Bucolo, ... PloS one 9 (5), e96905, 2014 | 584 | 2014 |
| Isoflavones: estrogenic activity, biological effect and bioavailability DC Vitale, C Piazza, B Melilli, F Drago, S Salomone European journal of drug metabolism and pharmacokinetics 38, 15-25, 2013 | 506 | 2013 |
| Omega‐3 fatty acids and depression: scientific evidence and biological mechanisms G Grosso, F Galvano, S Marventano, M Malaguarnera, C Bucolo, F Drago, ... Oxidative medicine and cellular longevity 2014 (1), 313570, 2014 | 433 | 2014 |
| A cannabinoid link between mitochondria and memory E Hebert-Chatelain, T Desprez, R Serrat, L Bellocchio, E Soria-Gomez, ... Nature 539 (7630), 555-559, 2016 | 425 | 2016 |
| New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs S Salomone, F Caraci, GM Leggio, J Fedotova, F Drago British journal of clinical pharmacology 73 (4), 504-517, 2012 | 417 | 2012 |
| Depression and Alzheimer's disease: neurobiological links and common pharmacological targets F Caraci, A Copani, F Nicoletti, F Drago European journal of pharmacology 626 (1), 64-71, 2010 | 375 | 2010 |
| Potential role of probiotics on colorectal cancer prevention M Uccello, G Malaguarnera, F Basile, V D’agata, M Malaguarnera, ... BMC surgery 12, 1-8, 2012 | 298 | 2012 |
| Identification of dopamine D1–D3 receptor heteromers: indications for a role of synergistic D1–D3 receptor interactions in the striatum D Marcellino, S Ferré, V Casadó, A Cortés, B Le Foll, C Mazzola, F Drago, ... Journal of Biological Chemistry 283 (38), 26016-26025, 2008 | 282 | 2008 |
| Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels M Van der Stelt, C Mazzola, G Esposito, I Matias, S Petrosino, DD Filippis, ... Cellular and Molecular Life Sciences CMLS 63, 1410-1424, 2006 | 260 | 2006 |
| Endocannabinoid system and mood disorders: priming a target for new therapies V Micale, V Di Marzo, A Sulcova, CT Wotjak, F Drago Pharmacology & therapeutics 138 (1), 18-37, 2013 | 254 | 2013 |
| Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory LM Robin, JFO da Cruz, VC Langlais, M Martin-Fernandez, ... Neuron 98 (5), 935-944. e5, 2018 | 228 | 2018 |
| TGF‐β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease F Caraci, G Battaglia, V Bruno, P Bosco, V Carbonaro, ML Giuffrida, ... CNS neuroscience & therapeutics 17 (4), 237-249, 2011 | 228 | 2011 |
| Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels V Micale, L Cristino, A Tamburella, S Petrosino, GM Leggio, F Drago, ... Neuropsychopharmacology 34 (3), 593-606, 2009 | 225 | 2009 |
| Antioxidants as antidepressants: fact or fiction? G Scapagnini, S Davinelli, F Drago, A De Lorenzo, G Oriani CNS drugs 26, 477-490, 2012 | 212 | 2012 |
| Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain S Chiechio, M Zammataro, ME Morales, CL Busceti, F Drago, RW Gereau, ... Molecular pharmacology 75 (5), 1014-1020, 2009 | 202 | 2009 |
| Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells R Foresti, SK Bains, TS Pitchumony, LE de Castro Brás, F Drago, ... Pharmacological research 76, 132-148, 2013 | 181 | 2013 |
| Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key P Castrogiovanni, M Di Rosa, S Ravalli, A Castorina, C Guglielmino, ... International journal of molecular sciences 20 (3), 511, 2019 | 176 | 2019 |
| Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-α nuclear receptors C Mazzola, J Medalie, M Scherma, LV Panlilio, M Solinas, G Tanda, ... Learning & memory 16 (5), 332-337, 2009 | 169 | 2009 |
| Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats C Bucolo, GM Leggio, F Drago, S Salomone Biochemical pharmacology 84 (1), 88-92, 2012 | 167 | 2012 |
| Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution ML Bondì, EF Craparo, G Giammona, F Drago Nanomedicine 5 (1), 25-32, 2010 | 166 | 2010 |
